Ascentage Pharma Group International 亞盛醫藥集團
Pay for financial year ended 2024-12-31
Source: Annual report
Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.
| Name | Last position |
Fees | Salary & benefits |
Bonus | Retire | Share- based |
Total | |
|---|---|---|---|---|---|---|---|---|
CNY '000 |
||||||||
Directors |
||||||||
| 1 | Bozilenko, Marina S | INED | 36 | 36 | ||||
| 2 | Lu, Simon Dazhong 呂大忠 | NED | ||||||
| 3 | Ren, Wei (1980) 任為 | INED | 427 | 52 | 479 | |||
| 4 | Sidransky, David | INED | 427 | 42 | 469 | |||
| 5 | Wang, Shaomeng 王少萌 | NED | 1,178 | 1,178 | ||||
| 6 | Yang, Dajun (1962) 楊大俊 | Ch, CEO, Co-Fdr | 3,917 | 273 | 4,190 | |||
| 7 | Ye, Benjamin Changqing 葉長青 | INED | 427 | 52 | 479 | |||
| 8 | Yin, Zheng (1971) 尹正 | INED | 186 | 52 | 238 | |||
| 9 | Yu, Debra Jiuyun 余久筠 | INED | 36 | 36 | ||||
| Total | 1,539 | 5,095 | 0 | 273 | 198 | 7,105 | ||
Main board pay history
Click on the year-end to see the pay details.
CNY'000
| Year-end | Fees | Salary & benefits |
Bonus | Retire | Share- based |
Total | |
|---|---|---|---|---|---|---|---|
| 2024-12-31 | 1,539 | 5,095 | 0 | 273 | 198 | 7,105 | Report |
| 2023-12-31 | 1,692 | 5,693 | 0 | 253 | 349 | 7,987 | Report |
| 2022-12-31 | 1,616 | 4,891 | 0 | 242 | 1,176 | 7,925 | Report |
| 2021-12-31 | 1,419 | 5,636 | 0 | 181 | 2,016 | 9,252 | Report |
| 2020-12-31 | 1,207 | 5,307 | 0 | 122 | 2,798 | 9,434 | Report |
| 2019-12-31 | 592 | 4,527 | 0 | 128 | 2,663 | 7,910 | Report |
| Total | 8,065 | 31,149 | 0 | 1,199 | 9,200 | 49,613 |
Want to see more years here? volunteer to be a Webb-database editor and add the data from annual reports!
Copyright & disclaimer, Privacy policy